Subscribe to our newsletter to receive the latest product updates and special offers

Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

RFL | Rafael Holdings, Inc.

Index- P/E- EPS (ttm)-0.65 Insider Own15.50% Shs Outstand23.37M Perf Week-8.81%
Market Cap51.15M Forward P/E- EPS next Y- Insider Trans0.00% Shs Float18.56M Perf Month-5.91%
Income-14.20M PEG- EPS next Q- Inst Own12.60% Short Float / Ratio0.39% / 3.21 Perf Quarter-1.90%
Sales0.30M P/S170.50 EPS this Y-349.50% Inst Trans-43.31% Short Interest0.07M Perf Half Y26.22%
Book/sh4.22 P/B0.49 EPS next Y- ROA-7.60% Target Price- Perf Year-5.05%
Cash/sh3.33 P/C0.62 EPS next 5Y- ROE-7.80% 52W Range1.55 - 2.52 Perf YTD10.70%
Dividend- P/FCF- EPS past 5Y- ROI-120.90% 52W High-17.86% Beta1.61
Dividend %- Quick Ratio60.30 Sales past 5Y-40.80% Gross Margin- 52W Low33.55% ATR0.09
Employees22 Current Ratio60.30 Sales Q/Q0.00% Oper. Margin- RSI (14)35.15 Volatility4.73% 3.87%
OptionableYes Debt/Eq0.00 EPS Q/Q75.50% Profit Margin- Rel Volume0.44 Prev Close2.15
ShortableYes LT Debt/Eq0.00 Earnings- Payout- Avg Volume22.40K Price2.07
Recom- SMA20-6.31% SMA50-5.09% SMA2001.58% Volume9,928 Change-3.72%
Aug-15-23 08:05AM
Aug-02-23 08:16AM
Jun-13-23 04:01PM
Jun-05-23 08:05AM
May-15-23 08:05AM
08:12AM Loading…
May-02-23 08:12AM
Apr-04-23 08:00AM
Mar-14-23 04:01PM
Dec-13-22 07:00AM
Nov-15-22 04:01PM
Oct-31-22 04:01PM
Sep-28-22 07:00AM
Aug-23-22 07:43AM
Aug-03-22 08:00AM
Jul-10-22 08:08AM
08:00AM Loading…
Jul-06-22 08:00AM
Jun-27-22 08:00AM
Jun-16-22 02:14PM
Jun-14-22 04:01PM
Jun-01-22 08:00AM
May-24-22 11:04AM
May-19-22 09:00AM
Mar-17-22 04:01PM
Feb-17-22 12:32PM
Jan-24-22 01:38PM
Jan-21-22 07:00AM
Jan-19-22 09:38AM
Jan-18-22 08:30AM
Jan-06-22 08:30AM
09:40AM Loading…
Dec-17-21 09:40AM
Dec-15-21 04:30PM
Dec-13-21 08:00AM
Nov-22-21 07:00AM
Nov-11-21 09:00AM
Nov-03-21 09:00AM
Oct-29-21 11:00AM
Oct-28-21 08:00AM
Oct-25-21 03:05PM
Oct-20-21 02:17AM
Oct-18-21 05:41PM
Oct-13-21 03:32PM
Oct-12-21 01:45PM
Oct-06-21 06:30AM
Sep-27-21 08:00AM
Sep-24-21 04:30PM
Sep-17-21 04:01PM
Sep-14-21 08:27AM
Sep-11-21 04:55PM
Sep-09-21 05:45PM
Sep-04-21 11:47AM
Sep-02-21 12:30PM
Sep-01-21 11:55AM
Aug-30-21 04:30PM
Aug-27-21 11:45AM
Aug-26-21 05:10PM
Aug-25-21 10:00AM
Aug-24-21 04:01PM
Aug-20-21 07:00AM
Aug-19-21 04:17PM
Aug-18-21 11:56AM
Aug-17-21 10:11AM
Aug-16-21 08:17AM
Aug-12-21 08:29PM
Aug-11-21 09:00AM
Aug-10-21 07:09PM
Aug-09-21 05:57PM
Aug-05-21 07:03PM
Aug-04-21 07:53PM
Aug-03-21 07:48PM
Aug-02-21 02:00PM
Jul-29-21 04:47PM
Jul-27-21 06:46PM
Jul-26-21 08:01AM
Jul-08-21 12:13PM
Jul-03-21 07:49PM
Jul-01-21 02:00PM
Jun-30-21 08:00AM
Jun-29-21 11:00AM
Jun-28-21 02:00PM
Rafael Holdings, Inc. holds interests in clinical and early stage pharmaceutical companies, and commercial real estate assets in the United States and Israel. It operates in two segments, Healthcare and Real Estate. The company engages in the development and commercialization of therapies that exploit the metabolic differences between normal cells and cancer cells. Its lead drug candidate is CPI-613 (devimistat), that is in Phase III clinical study for the treatment of metastatic pancreatic cancer and acute myeloid leukemia. Rafael Holdings, Inc. was incorporated in 2017 and is headquartered in Newark, New Jersey.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Rafael Holdings, Inc.10% OwnerAug 01Buy1.254,000,0005,000,0006,514,970Aug 02 04:43 PM